• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Concomitant benzodiazepine use attenuates ketamine response: implications for large scale study design and clinical development.

作者信息

Frye Mark A, Blier Pierre, Tye Susannah J

机构信息

Department of Psychiatry and Psychology Mayo Clinic Depression Center Mayo Clinic Rochester, MN

出版信息

J Clin Psychopharmacol. 2015 Jun;35(3):334-6. doi: 10.1097/JCP.0000000000000316.

DOI:10.1097/JCP.0000000000000316
PMID:25928701
Abstract
摘要

相似文献

1
Concomitant benzodiazepine use attenuates ketamine response: implications for large scale study design and clinical development.同时使用苯二氮䓬类药物会减弱氯胺酮的反应：对大规模研究设计和临床开发的启示。
J Clin Psychopharmacol. 2015 Jun;35(3):334-6. doi: 10.1097/JCP.0000000000000316.
2
Benzodiazepines may reduce the effectiveness of ketamine in the treatment of depression.苯二氮䓬类药物可能会降低氯胺酮治疗抑郁症的疗效。
Aust N Z J Psychiatry. 2015 Dec;49(12):1227. doi: 10.1177/0004867415590631. Epub 2015 Jun 9.
3
Ketamine helps a third of patients with treatment resistant depression, finds small UK study.英国小型研究发现，氯胺酮对三分之一难治性抑郁症患者有帮助。
BMJ. 2014 Apr 3;348:g2576. doi: 10.1136/bmj.g2576.
4
The Antidepressant Effect of Repeat Dose Intravenous Ketamine Is Delayed by Concurrent Benzodiazepine Use.重复剂量静脉注射氯胺酮的抗抑郁作用会因同时使用苯二氮䓬类药物而延迟。
J Clin Psychiatry. 2017 Mar;78(3):e308-e309. doi: 10.4088/JCP.16l11277.
5
[Ketamine--a new treatment option for therapy-resistant depression].[氯胺酮——难治性抑郁症的一种新治疗选择]
Fortschr Neurol Psychiatr. 2015 Feb;83(2):91-7. doi: 10.1055/s-0034-1398967. Epub 2015 Feb 27.
6
Intravenous ketamine for treatment-resistant major depressive disorder.静脉注射氯胺酮治疗难治性重度抑郁症。
Ann Pharmacother. 2012 Jan;46(1):117-23. doi: 10.1345/aph.1Q371. Epub 2011 Dec 20.
7
Frontiers in Therapy of Treatment-Resistant-Depression: A Future Role of Ketamine?难治性抑郁症的治疗前沿：氯胺酮的未来作用？
J Okla State Med Assoc. 2015 Mar;108(3):88-9.
8
Ketamine: Future Treatment For Unresponsive Depression?氯胺酮：治疗难治性抑郁症的未来疗法？
Ir Med J. 2016 Sep 9;109(8):453.
9
Oral ketamine augmentation for chronic suicidality in treatment-resistant depression.口服氯胺酮增效治疗难治性抑郁症中的慢性自杀倾向。
Aust N Z J Psychiatry. 2014 Jul;48(7):686. doi: 10.1177/0004867414520754. Epub 2014 Jan 22.
10
Ketamine treatment for depression: opportunities for clinical innovation and ethical foresight.氯胺酮治疗抑郁症：临床创新与伦理前瞻性的机遇。
Lancet Psychiatry. 2017 May;4(5):419-426. doi: 10.1016/S2215-0366(17)30102-5. Epub 2017 Apr 5.

引用本文的文献

1
Lamotrigine is not associated with differential clinical outcomes in a real-world sample of patients with unipolar depression receiving ketamine or esketamine.在接受氯胺酮或艾氯胺酮治疗的单相抑郁症患者的真实样本中，拉莫三嗪与不同的临床结果无关。
Psychopharmacology (Berl). 2025 Sep 20. doi: 10.1007/s00213-025-06896-7.
2
Abuse liability for esketamine in a cohort of patients undergoing an acute treatment course to manage treatment-resistant depression: a secondary analysis of an observational study in real-world clinical practicee.在一组接受急性治疗疗程以管理难治性抑郁症的患者中艾氯胺酮的滥用可能性：一项真实世界临床实践中观察性研究的二次分析
Ther Adv Drug Saf. 2025 Jun 19;16:20420986251347360. doi: 10.1177/20420986251347360. eCollection 2025.
3
High Baseline Plasma Anthranilic Acid Predicts Remission Upon Acute-Series Ketamine Infusion for Treatment-Resistant Depression.高基线血浆邻氨基苯甲酸可预测难治性抑郁症急性系列氯胺酮输注后的缓解情况。
Biol Psychiatry Glob Open Sci. 2025 Apr 12;5(4):100503. doi: 10.1016/j.bpsgos.2025.100503. eCollection 2025 Jul.
4
Baseline perceived stress as a predictor of ketamine/esketamine treatment response in treatment-resistant depression.基线感知压力作为难治性抑郁症中氯胺酮/艾氯胺酮治疗反应的预测指标。
J Affect Disord. 2025 Aug 15;383:283-289. doi: 10.1016/j.jad.2025.04.117. Epub 2025 Apr 25.
5
Acute subanesthetic ketamine-induced effects on the mismatch negativity and their relationship to early and sustained treatment response in major depressive disorder.急性亚麻醉剂量氯胺酮对失配负波的影响及其与重度抑郁症早期和持续治疗反应的关系。
J Psychopharmacol. 2025 Jun;39(6):577-592. doi: 10.1177/02698811251319456. Epub 2025 Feb 26.
6
Personalized use of ketamine and esketamine for treatment-resistant depression.个体化使用氯胺酮和艾司氯胺酮治疗难治性抑郁症。
Transl Psychiatry. 2024 Nov 29;14(1):481. doi: 10.1038/s41398-024-03180-8.
7
Esketamine in depression: putative biomarkers from clinical research.艾氯胺酮治疗抑郁症：临床研究中的潜在生物标志物
Eur Arch Psychiatry Clin Neurosci. 2024 Jul 13. doi: 10.1007/s00406-024-01865-1.
8
Antagonistic interaction between caffeine and ketamine in zebrafish: Implications for aquatic toxicity.咖啡因与氯胺酮在斑马鱼中的拮抗相互作用：对水生毒性的影响。
Environ Sci Ecotechnol. 2024 Jun 10;21:100437. doi: 10.1016/j.ese.2024.100437. eCollection 2024 Sep.
9
Ketamine vs Electroconvulsive Therapy for Treatment-Resistant Depression: A Secondary Analysis of a Randomized Clinical Trial.氯胺酮与电抽搐治疗抵抗性抑郁症的比较：一项随机临床试验的二次分析。
JAMA Netw Open. 2024 Jun 3;7(6):e2417786. doi: 10.1001/jamanetworkopen.2024.17786.
10
Ketamine for postoperative avoidance of depressive symptoms: the K-PASS feasibility randomised trial.氯胺酮用于术后预防抑郁症状：K-PASS可行性随机试验
BJA Open. 2023 Dec 15;9:100245. doi: 10.1016/j.bjao.2023.100245. eCollection 2024 Mar.